News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
George Medicines Receives FDA Approval for WIDAPLIK™, a New Single-Pill Combination Treatment for Hypertension in Adults
Monday, June 09, 2025George Medicines a biopharmaceutical company focused on cardiometabolic conditions has received approval from the US Food and Drug Administration FDA for WIDAPLIK telmisartan amlodipine and indapamide
Alvotech and Dr. Reddy’s Collaborate on Biosimilar for Keytruda® (pembrolizumab)
Friday, June 06, 2025Alvotech a global biotechnology firm focused on developing and producing biosimilar medicines has entered into a collaboration and licensing agreement with Dr Reddys Laboratories to codevelop manufacture
Mission Bio Launches Single-Cell Genotype and Targeted Gene Expression Assay to Support Cancer Drug Development
Friday, June 06, 2025Mission Bio has introduced a new SingleCell Genotype and Targeted Gene Expression assay marking a significant addition to its Tapestri Platform This is the first commercial solution that combines both genotype and targeted gene expression analysis
Oncovita Receives U.S. FDA Orphan Drug Designation for MVdeltaC in Treating Pleural Mesothelioma
Thursday, June 05, 2025Oncovita a biotechnology company focused on virusbased immunotherapies has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for its lead candidate MVdeltaC
Cadonilimab Approved in China for First-Line Treatment of Cervical Cancer—Third Indication for Akeso’s Bispecific Antibody
Thursday, June 05, 2025Akeso Inc has received approval from Chinas National Medical Products Administration NMPA for the use of its PDCTLA bispecific antibody cadonilimab as a firstline treatment for patients with persistent recurrent or metastatic cervical cancer The ther...
Camurus and Lilly Sign Agreement for Global Development of Long-Acting FluidCrystal® Incretins
Wednesday, June 04, 2025Camurus and Eli Lilly and Company have entered into a collaboration and licence agreement that gives Lilly exclusive global rights to develop produce and market longacting incretinbased treatments
Transpire Bio Signs Exclusive Licensing Deal with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
Wednesday, June 04, 2025Transpire Bio Inc a clinicalstage biopharmaceutical company based in the United States and specialising in inhaled treatments for lung and systemic diseases has entered into an exclusive licensing agreement with Suzhou Intragrand Pharma Co
BioNTech and Bristol Myers Squibb Form Global Partnership to Develop and Market Bispecific Antibody BNT327 for Solid Tumours
Tuesday, June 03, 2025BioNTech SE and Bristol Myers Squibb BMS have entered into a global strategic partnership to codevelop and cocommercialise BNT an experimental bispecific antibody being developed for the treatment of various solid tumours
ASP Isotopes and Isotopia Sign Agreement to Supply Gadolinium-160 for Terbium-161 Production in Cancer Treatment
Tuesday, June 03, 2025ASP Isotopes Inc and Isotopia Molecular Imaging Ltd have entered into a supply agreement focused on Gadolinium Gd a vital stable isotope used in the production of Terbium Tb
Nxera Pharma Reaches Key Development Milestone in Partnership with Eli Lilly for Metabolic Disease Treatments
Monday, June 02, 2025Nxera Pharma Co Ltdhas reached a significant development milestone as part of its ongoing multitarget collaboration and licence agreement with Eli Lilly and Company This achievement relates to research efforts
